Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 23235 | 298 | 45.5 | 91% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 892 | 10711 | JOURNAL OF INTERFERON RESEARCH//ISG15//JOURNAL OF INTERFERON AND CYTOKINE RESEARCH |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ISG15 | Author keyword | 58 | 61% | 21% | 62 |
| 2 | ISGYLATION | Author keyword | 45 | 94% | 5% | 16 |
| 3 | HERC5 | Author keyword | 12 | 86% | 2% | 6 |
| 4 | UBE1L | Author keyword | 8 | 75% | 2% | 6 |
| 5 | UBP43 | Author keyword | 8 | 75% | 2% | 6 |
| 6 | USP18 | Author keyword | 6 | 50% | 3% | 9 |
| 7 | HERC | Author keyword | 4 | 67% | 1% | 4 |
| 8 | HERC1 | Author keyword | 4 | 67% | 1% | 4 |
| 9 | GIANT PROTEINS | Author keyword | 2 | 67% | 1% | 2 |
| 10 | RCC1 LIKE DOMAIN | Author keyword | 2 | 67% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ISG15 | 58 | 61% | 21% | 62 | Search ISG15 | Search ISG15 |
| 2 | ISGYLATION | 45 | 94% | 5% | 16 | Search ISGYLATION | Search ISGYLATION |
| 3 | HERC5 | 12 | 86% | 2% | 6 | Search HERC5 | Search HERC5 |
| 4 | UBE1L | 8 | 75% | 2% | 6 | Search UBE1L | Search UBE1L |
| 5 | UBP43 | 8 | 75% | 2% | 6 | Search UBP43 | Search UBP43 |
| 6 | USP18 | 6 | 50% | 3% | 9 | Search USP18 | Search USP18 |
| 7 | HERC | 4 | 67% | 1% | 4 | Search HERC | Search HERC |
| 8 | HERC1 | 4 | 67% | 1% | 4 | Search HERC1 | Search HERC1 |
| 9 | GIANT PROTEINS | 2 | 67% | 1% | 2 | Search GIANT+PROTEINS | Search GIANT+PROTEINS |
| 10 | RCC1 LIKE DOMAIN | 2 | 67% | 1% | 2 | Search RCC1+LIKE+DOMAIN | Search RCC1+LIKE+DOMAIN |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ISGYLATION | 73 | 96% | 8% | 23 |
| 2 | UBP43 USP18 | 51 | 79% | 11% | 33 |
| 3 | ISG15 | 34 | 51% | 16% | 48 |
| 4 | UBIQUITIN LIKE PROTEIN | 25 | 24% | 31% | 92 |
| 5 | STIMULATED GENE 15 | 22 | 55% | 9% | 28 |
| 6 | PROTEIN ISGYLATION | 20 | 100% | 3% | 9 |
| 7 | UBP43 | 17 | 79% | 4% | 11 |
| 8 | ISG15 MODIFICATION | 17 | 75% | 4% | 12 |
| 9 | ANTIVIRAL MOLECULE | 16 | 60% | 6% | 18 |
| 10 | INTERFERON STIMULATED GENE 15 | 10 | 73% | 3% | 8 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Interferon-Stimulated Gene 15 and the Protein ISGylation System | 2011 | 68 | 108 | 73% |
| Emerging Role of ISG15 in Antiviral Immunity | 2010 | 81 | 20 | 100% |
| The Antiviral Activities of ISG15 | 2013 | 21 | 81 | 72% |
| Interferon-induced ISG15 pathway: an ongoing virus-host battle | 2013 | 20 | 55 | 65% |
| ISG15 and immune diseases | 2010 | 42 | 173 | 47% |
| Antiviral Properties of ISG15 | 2010 | 12 | 59 | 85% |
| Activation of endogenous type I IFN signaling contributes to persistent HCV infection | 2014 | 3 | 79 | 35% |
| Antiviral Activity of Innate Immune Protein ISG15 | 2009 | 40 | 72 | 36% |
| ISG15: leading a double life as a secreted molecule | 2013 | 11 | 72 | 35% |
| IFNs, ISGylation and cancer: Cui prodest? | 2012 | 7 | 112 | 53% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CIENCIES FISIOLOG 2 | 1 | 50% | 0.3% | 1 |
| 2 | DDC CLIN | 1 | 50% | 0.3% | 1 |
| 3 | INSERMNECKER BRANCHU980 | 1 | 50% | 0.3% | 1 |
| 4 | MOL GENET BANTING BEST | 1 | 50% | 0.3% | 1 |
| 5 | PROMEC CORE IL PROTE METABOL | 1 | 50% | 0.3% | 1 |
| 6 | UNIT BIOQUIM BIOL MOL | 1 | 50% | 0.3% | 1 |
| 7 | MOO UNIV CALIF SAN DIEGO CANC | 1 | 19% | 1.0% | 3 |
| 8 | PREVENT MED PUBL HLTH MICROBIOL | 0 | 20% | 0.7% | 2 |
| 9 | MICROBIOL TRAINING AREA | 0 | 33% | 0.3% | 1 |
| 10 | CANC PROTE IL | 0 | 25% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000157638 | IFITM3//IFITM1//IFITM |
| 2 | 0.0000148749 | INTERFERON RECEPTOR//IFNAR2//IFNAR1 |
| 3 | 0.0000141867 | MX PROTEIN//MX GENE//MXA PROTEIN |
| 4 | 0.0000119416 | IFN LAMBDA//IL 29//INTERLEUKIN 29 |
| 5 | 0.0000116784 | ISOFATTY ACID//COOPERAT MED//MNSF BETA |
| 6 | 0.0000112274 | RIG I//IRF3//MDA5 |
| 7 | 0.0000110052 | USP22//UCH L1//DEUBIQUITINATING ENZYME |
| 8 | 0.0000102147 | DSK2//UBIQUILIN 1//LUBAC |
| 9 | 0.0000096119 | INTERFERON TAU//ANIM BIOTECHNOL GENOM//CONCEPTUS |
| 10 | 0.0000081755 | FAT10//MALLORY BODY//MALLORY DENK BODIES MDBS |